Literature DB >> 32101482

Region-specific effects of HIV-1 Tat on intrinsic electrophysiological properties of pyramidal neurons in mouse prefrontal cortex and hippocampus.

Thomas J Cirino1, Scott W Harden1, Jay P McLaughlin1, Charles J Frazier1.   

Abstract

Human immunodeficiency virus (HIV)-1 transactivator of transcription protein (Tat) is a viral protein that promotes transcription of the HIV genome and possesses cell-signaling properties. Long-term exposure of central nervous system (CNS) tissue to HIV-1 Tat is theorized to contribute to HIV-associated neurodegenerative disorder (HAND). In the current study, we sought to directly evaluate the effect of HIV-1 Tat expression on the intrinsic electrophysiological properties of pyramidal neurons located in layer 2/3 of the medial prefrontal cortex and in area CA1 of the hippocampus. Toward that end, we drove Tat expression with doxycycline (100 mg·kg-1·day-1 ip) in inducible Tat (iTat) transgenic mice for 7 days and then performed single-cell electrophysiological studies in acute tissue slices made through the prefrontal cortex and hippocampus. Control experiments were performed in doxycycline-treated G-tg mice, which retain the tetracycline-sensitive promoter but do not express Tat. Our results indicated that the predominant effects of HIV-1 Tat expression are excitatory in medial prefrontal cortical pyramidal neurons yet inhibitory in hippocampal pyramidal neurons. Notably, in these two populations, HIV-1 Tat expression produced differential effects on neuronal gain, membrane time constant, resting membrane potential, and rheobase. Similarly, we also observed distinct effects on action potential kinetics and afterhyperpolarization, as well as on the current-voltage relationship in subthreshold voltage ranges. Collectively, these data provide mechanistic evidence of complex and region-specific changes in neuronal physiology by which HIV-1 Tat protein may promote cognitive deficits associated with HAND.NEW & NOTEWORTHY We drove expression of human immunodeficiency virus (HIV)-1 transactivator of transcription protein (Tat) protein in inducible Tat (iTat) transgenic mice for 7 days and then examined the effects on the intrinsic electrophysiological properties of pyramidal neurons located in the medial prefrontal cortex (mPFC) and in the hippocampus. Our results reveal a variety of specific changes that promote increased intrinsic excitability of layer II/III mPFC pyramidal neurons and decreased intrinsic excitability of hippocampal CA1 pyramidal neurons, highlighting both cell type and region-specific effects.

Entities:  

Keywords:  HIV; Tat; electrophysiology; hippocampus; prefrontal cortex

Mesh:

Substances:

Year:  2020        PMID: 32101482      PMCID: PMC7191522          DOI: 10.1152/jn.00029.2020

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  55 in total

1.  F-actin at newly invaginated membrane in neurons: implications for surface area regulation.

Authors:  T L Herring; C S Cohan; E A Welnhofer; L R Mills; C E Morris
Journal:  J Membr Biol       Date:  1999-09-15       Impact factor: 1.843

2.  Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.

Authors:  T Celeste Napier; Lihua Chen; Fatah Kashanchi; Xiu-Ti Hu
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-25       Impact factor: 4.147

3.  Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Brain Res       Date:  2008-07-17       Impact factor: 3.252

4.  Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site.

Authors:  L Song; A Nath; J D Geiger; A Moore; S Hochman
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

5.  Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.

Authors:  Changqing Xu; Douglas J Hermes; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-18       Impact factor: 4.147

6.  Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing.

Authors:  Taha Mohseni Ahooyi; Masoud Shekarabi; Bahareh Torkzaban; T Dianne Langford; Tricia H Burdo; Jennifer Gordon; Prasun K Datta; Shohreh Amini; Kamel Khalili
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

7.  Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice.

Authors:  Jason J Paris; Amanda N Carey; Christopher F Shay; Stacey M Gomes; Johnny J He; Jay P McLaughlin
Journal:  Neuropsychopharmacology       Date:  2013-08-15       Impact factor: 7.853

8.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

9.  Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.

Authors:  Anantha Ram Nookala; Anil Kumar
Journal:  J Neuroinflammation       Date:  2014-12-24       Impact factor: 8.322

10.  HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.

Authors:  John P Norman; Seth W Perry; Holly M Reynolds; Michelle Kiebala; Karen L De Mesy Bentley; Margarita Trejo; David J Volsky; Sanjay B Maggirwar; Stephen Dewhurst; Eliezer Masliah; Harris A Gelbard
Journal:  PLoS One       Date:  2008-11-14       Impact factor: 3.240

View more
  14 in total

Review 1.  HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative Treatments.

Authors:  Adonira Saro; Zhaolin Gao; Piniel Alphayo Kambey; Paul Pielnaa; Dama Faniriantsoa Henrio Marcellin; Aixiang Luo; Ruping Zheng; Zhongjun Huang; Lvshuang Liao; Mingxuan Zhao; Liangpeng Suo; Shuang Lu; Min Li; Deyang Cai; Dan Chen; Haiyang Yu; Jufang Huang
Journal:  Cell Mol Neurobiol       Date:  2021-09-25       Impact factor: 4.231

2.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

3.  In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain.

Authors:  Jason J Paris; Xi Chen; Joseph Anderson; Alaa N Qrareya; Fakhri Mahdi; Fei Du; Jay P McLaughlin; Marc J Kaufman
Journal:  Geroscience       Date:  2021-04-05       Impact factor: 7.713

Review 4.  Mini-review: The therapeutic role of cannabinoids in neuroHIV.

Authors:  Barkha J Yadav-Samudrala; Sylvia Fitting
Journal:  Neurosci Lett       Date:  2021-02-12       Impact factor: 3.046

5.  HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure.

Authors:  William D Marks; Jason J Paris; Aaron J Barbour; Jean Moon; Valerie J Carpenter; Virginia D McLane; Arianna R S Lark; Sara R Nass; Jingli Zhang; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  eNeuro       Date:  2021-05-24

Review 6.  Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.

Authors:  Elena Irollo; Jared Luchetta; Chunta Ho; Bradley Nash; Olimpia Meucci
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 7.  Mini-review: Elucidating the psychological, physical, and sex-based interactions between HIV infection and stress.

Authors:  Hannah Stadtler; Gladys Shaw; Gretchen N Neigh
Journal:  Neurosci Lett       Date:  2021-02-01       Impact factor: 3.197

8.  Alteration of the cholinergic system and motor deficits in cholinergic neuron-specific Dyt1 knockout mice.

Authors:  Yuning Liu; Hong Xing; Wanhui Sheng; Kyle N Singh; Alexandra G Korkmaz; Caroline Comeau; Maisha Anika; Alexis Ernst; Fumiaki Yokoi; David E Vaillancourt; Charles J Frazier; Yuqing Li
Journal:  Neurobiol Dis       Date:  2021-03-20       Impact factor: 7.046

9.  HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses.

Authors:  Mariah M Wu; Stanley A Thayer
Journal:  eNeuro       Date:  2020-06-19

10.  HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus.

Authors:  Sara R Nass; Arianna R S Lark; Yun K Hahn; Virginia D McLane; Therese M Ihrig; Liangru Contois; T Celeste Napier; Pamela E Knapp; Kurt F Hauser
Journal:  Horm Behav       Date:  2021-06-23       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.